Skip to content

Effect of catheter indwelling time on the incidence and severity of early urinary incontinence after enucleation of prostatic hyperplasia: a prospective randomized controlled study

Effect of catheter indwelling time on the incidence and severity of early urinary incontinence after enucleation of prostatic hyperplasia: a prospective randomized controlled study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500099344
Enrollment
Unknown
Registered
2025-03-21
Start date
2024-08-15
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Benign Prostatic Hyperplasia

Interventions

experimental group:The urethral catheter was removed 7 days +/- 1 day after surgery
control group:Drainage of urinary tube <=3 days after operation

Sponsors

Beijing Chaoyang Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: (1) In accordance with the diagnostic criteria for BPH in Chinese Guidelines for the Diagnosis and Treatment of Urology and Andrology Diseases: 2022 Edition, BPH was confirmed by comprehensive examination such as imaging and rectal examination; (2) Having surgical indications; (3) Complete clinical data.

Exclusion criteria

Exclusion criteria: (1) Combined with neurogenic bladder dysfunction; (2) Previous urinary tract stenosis; (3) Combined with prostate cancer; (4) Combined with acute urinary tract infection; (5) Combined with abnormal coagulation function; (6) the presence of serious heart disease, kidney disease or other serious underlying diseases; (7) Previous prostate surgery history. (8) Poor compliance and risk of follow-up loss.

Design outcomes

Primary

MeasureTime frame
Whether you have urinary incontinence;IPSS scores;QOL scores;OABSS scores;Maximum urinary flow rate Qmax;Residual urine PVR;Number of urinal pads used in 24 hours;

Secondary

MeasureTime frame
prostate volume;Free prostatic specific antigen;

Countries

China

Contacts

Public ContactJianwen Wang

Beijing Chaoyang Hospital, Capital Medical University

wjianw999@163.com+86 139 1081 8269

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026